Summary - The ASCO Post

Discussing Breast Density With Patients Following the FDA Mammography Quality Standards Act Mandate

A recent report provided a concise, evidence-based summary to help clinicians discuss information regarding breast density and implement shared decision-making with patients following the U.S. Food and Drug Administration (FDA) Mammography Quality Standards Act mandate.

Julia Cipriano

The ASCO Post 03/10/25 9:37 AM

Lee et al's article in JAMA provides a concise, evidence-based summary on breast density, its impact on breast cancer screening, and the FDA mandate concerning breast density information disclosure to patients. The article emphasizes the importance of shared decision-making between clinicians and patients, particularly for women with dense breasts, and discusses the relevance of risk assessment tools for determining appropriate screening strategies. It also highlights the consideration of individual patient values in the decision-making process regarding supplemental screening.